236 related articles for article (PubMed ID: 20729256)
21. Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS.
Morgen K; Sammer G; Courtney SM; Wolters T; Melchior H; Blecker CR; Oschmann P; Kaps M; Vaitl D
Neuroimage; 2006 Apr; 30(3):891-8. PubMed ID: 16360321
[TBL] [Abstract][Full Text] [Related]
22. Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclerosis.
Gadea M; Martínez-Bisbal MC; Marti-Bonmatí L; Espert R; Casanova B; Coret F; Celda B
Brain; 2004 Jan; 127(Pt 1):89-98. PubMed ID: 14506072
[TBL] [Abstract][Full Text] [Related]
23. One-year follow-up study of relapsing-remitting MS patients' cognitive performances: Paced Auditory Serial Addition Test's susceptibility to change.
Rosti E; Hämäläinen P; Koivisto K; Hokkanen L
J Int Neuropsychol Soc; 2007 Sep; 13(5):791-8. PubMed ID: 17697410
[TBL] [Abstract][Full Text] [Related]
24. Cortical thickness and surface area relate to specific symptoms in early relapsing-remitting multiple sclerosis.
Nygaard GO; Walhovd KB; Sowa P; Chepkoech JL; Bjørnerud A; Due-Tønnessen P; Landrø NI; Damangir S; Spulber G; Storsve AB; Beyer MK; Fjell AM; Celius EG; Harbo HF
Mult Scler; 2015 Apr; 21(4):402-14. PubMed ID: 25139946
[TBL] [Abstract][Full Text] [Related]
25. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
[TBL] [Abstract][Full Text] [Related]
26. Anatomical brain connectivity can assess cognitive dysfunction in multiple sclerosis.
Bozzali M; Spanò B; Parker GJ; Giulietti G; Castelli M; Basile B; Rossi S; Serra L; Magnani G; Nocentini U; Caltagirone C; Centonze D; Cercignani M
Mult Scler; 2013 Aug; 19(9):1161-8. PubMed ID: 23325589
[TBL] [Abstract][Full Text] [Related]
27. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
Bergendal G; Fredrikson S; Almkvist O
Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
[TBL] [Abstract][Full Text] [Related]
28. Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis.
Bellmann-Strobl J; Wuerfel J; Aktas O; Dörr J; Wernecke KD; Zipp F; Paul F
Neurology; 2009 Nov; 73(20):1624-7. PubMed ID: 19917984
[TBL] [Abstract][Full Text] [Related]
29. Short-term brain atrophy changes in relapsing-remitting multiple sclerosis.
Zivadinov R; Bagnato F; Nasuelli D; Bastianello S; Bratina A; Locatelli L; Watts K; Finamore L; Grop A; Dwyer M; Catalan M; Clemenzi A; Millefiorini E; Bakshi R; Zorzon M
J Neurol Sci; 2004 Aug; 223(2):185-93. PubMed ID: 15337621
[TBL] [Abstract][Full Text] [Related]
30. PASAT in detecting cognitive impairment in relapsing-remitting MS.
Rosti E; Hämäläinen P; Koivisto K; Hokkanen L
Appl Neuropsychol; 2007; 14(2):101-12. PubMed ID: 17523884
[TBL] [Abstract][Full Text] [Related]
31. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.
Calabrese M; Rocca MA; Atzori M; Mattisi I; Favaretto A; Perini P; Gallo P; Filippi M
Ann Neurol; 2010 Mar; 67(3):376-83. PubMed ID: 20373349
[TBL] [Abstract][Full Text] [Related]
32. Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study.
Horakova D; Dwyer MG; Havrdova E; Cox JL; Dolezal O; Bergsland N; Rimes B; Seidl Z; Vaneckova M; Zivadinov R
J Neurol Sci; 2009 Jul; 282(1-2):112-9. PubMed ID: 19168190
[TBL] [Abstract][Full Text] [Related]
33. Social cognition impairments in relapsing-remitting multiple sclerosis.
Henry A; Tourbah A; Chaunu MP; Rumbach L; Montreuil M; Bakchine S
J Int Neuropsychol Soc; 2011 Nov; 17(6):1122-31. PubMed ID: 22014035
[TBL] [Abstract][Full Text] [Related]
34. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
Tedeschi G; Dinacci D; Comerci M; Lavorgna L; Savettieri G; Quattrone A; Livrea P; Patti F; Morra VB; Servillo G; Orefice G; Paciello M; Prinster A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Brunetti A; Salemi G; D'Amelio M; Simone I; Salvatore M; Bonavita V; Alfano B
Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104
[TBL] [Abstract][Full Text] [Related]
35. Cognitive impairment as unusual first manifestation in late-onset relapsing-remitting multiple sclerosis.
Etgen T; Adler-Hunklinger U; Hemmer B
Acta Neurol Belg; 2012 Sep; 112(3):307-9. PubMed ID: 22476976
[No Abstract] [Full Text] [Related]
36. Corpus callosum function in verbal dichotic listening: inferences from a longitudinal follow-up of Relapsing-Remitting Multiple Sclerosis patients.
Gadea M; Marti-Bonmatí L; Arana E; Espert R; Salvador A; Casanova B
Brain Lang; 2009 Aug; 110(2):101-5. PubMed ID: 19419759
[TBL] [Abstract][Full Text] [Related]
37. Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS.
Strober L; Englert J; Munschauer F; Weinstock-Guttman B; Rao S; Benedict RH
Mult Scler; 2009 Sep; 15(9):1077-84. PubMed ID: 19556311
[TBL] [Abstract][Full Text] [Related]
38. Neuropsychological testing and event-related potentials in the assessment of cognitive performance in the patients with multiple sclerosis--a pilot study.
Pokryszko-Dragan A; Zagrajek M; Slotwinski K; Gruszka E; Bilinska M; Podemski R
Clin Neurol Neurosurg; 2009 Jul; 111(6):503-6. PubMed ID: 19233546
[TBL] [Abstract][Full Text] [Related]
39. The relationship between regional microstructural abnormalities of the corpus callosum and physical and cognitive disability in relapsing-remitting multiple sclerosis.
Caligiuri ME; Barone S; Cherubini A; Augimeri A; Chiriaco C; Trotta M; Granata A; Filippelli E; Perrotta P; Valentino P; Quattrone A
Neuroimage Clin; 2015; 7():28-33. PubMed ID: 25610764
[TBL] [Abstract][Full Text] [Related]
40. Regional hippocampal atrophy in multiple sclerosis.
Sicotte NL; Kern KC; Giesser BS; Arshanapalli A; Schultz A; Montag M; Wang H; Bookheimer SY
Brain; 2008 Apr; 131(Pt 4):1134-41. PubMed ID: 18375977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
